Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human bombesin receptor subtype-3sb

Human bombesin receptor subtype-3sb

US Patent 6143521 · Granted Nov 7, 2000

Estimated economic value: $23,407,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) nano-formulation2025
Humanized anti-C5 antibodies and uses thereof2024
Molecules with altered neonate Fc receptor binding having enhanced therapeutic a2023
Nucleic acids encoding anti-VEGF-A antibodies and uses thereof2023
Nucleic acids encoding bispecific anti-VEGF and anti-ANG2 antibodies and uses th2023
Antibodies specific for IL-21 and uses thereof2022
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and me2021
Anti-VEGF-A antibodies and uses thereof2021
Anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds and me2021
Anti-VEGF-A and anti-ANG2 antibodies and uses thereof2020
Antibodies specific for IL-21 and uses thereof2020
Anti-endothelial lipase compounds and methods of using the same in the treatment2019